Resultados de búsqueda - Barry E. Rosenbloom

  • Mostrando 1 - 9 Resultados de 9
Limitar resultados
  1. 1
    Gaucher Disease and Malignancy: A Model for Cancer Pathogenesis in an Inborn Error of Metabolism

    Gaucher Disease and Malignancy: A Model for Cancer Pathogenesis in an Inborn Error of Metabolism por Pramod K. Mistry, Tamar H. Taddei, Stephan vom Dahl, Barry E. Rosenbloom

    Publicado 2013
    Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  2. 2
    Enzyme replacement therapy for Gaucher disease

    Enzyme replacement therapy for Gaucher disease por Ernest Beutler, Andrea Kay, Alan Saven, Paul Garver, Dennis Thurston, Arthur Dawson, Barry E. Rosenbloom

    Publicado 1991
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  3. 3
    A Less Costly Regimen of Alglucerase to Treat Gaucher's Disease

    A Less Costly Regimen of Alglucerase to Treat Gaucher's Disease por Michael L. Figueroa, Barry E. Rosenbloom, Andrea Kay, Paul Garver, Dennis Thurston, James A. Koziol, Terri Gelbart, Ernest Beutler

    Publicado 1992
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  4. 4
    The incidence of Parkinsonism in patients with type 1 Gaucher disease: Data from the ICGG Gaucher Registry

    The incidence of Parkinsonism in patients with type 1 Gaucher disease: Data from the ICGG Gaucher Registry por Barry E. Rosenbloom, Manisha Balwani, Jeff M. Bronstein, Edwin H. Kolodny, Swati Sathe, A. R. Gwosdow, John S. Taylor, J. Alexander Cole, Ari Zimran, Neal J. Weinreb

    Publicado 2010
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  5. 5
    ENCORE: A randomized, controlled, open-label non-inferiority study comparing eliglustat to imiglucerase in Gaucher disease type 1 patients on enzyme replacement therapy who have reached therapeutic goals

    ENCORE: A randomized, controlled, open-label non-inferiority study comparing eliglustat to imiglucerase in Gaucher disease type 1 patients on enzyme replacement therapy who have re... por Timothy M. Cox, Guillermo Drelichman, Renata Cravo, Manisha Balwani, Thomas Andrew Burrow, Ana Maria Martins, Elena Lukina, Barry E. Rosenbloom, Leorah Ross, Jennifer Angell, Ana Cristina Puga

    Publicado 2014
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  6. 6
    Transformation in pretreatment manifestations of Gaucher disease type 1 during two decades of alglucerase/imiglucerase enzyme replacement therapy in the International Collaborative Gaucher Group (ICGG) Gaucher Registry

    Transformation in pretreatment manifestations of Gaucher disease type 1 during two decades of alglucerase/imiglucerase enzyme replacement therapy in the International Collaborative... por Pramod K. Mistry, Julie L. Batista, Hans C. Andersson, Manisha Balwani, Thomas Andrew Burrow, Joel Charrow, Paige Kaplan, Anzalee Khan, Priya S. Kishnani, Edwin H. Kolodny, Barry E. Rosenbloom, C. Ronald Scott, Neal J. Weinreb

    Publicado 2017
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  7. 7
    Eliglustat maintains long-term clinical stability in patients with Gaucher disease type 1 stabilized on enzyme therapy

    Eliglustat maintains long-term clinical stability in patients with Gaucher disease type 1 stabilized on enzyme therapy por Timothy M. Cox, Guillermo Drelichman, Renata Cravo, Manisha Balwani, Thomas Andrew Burrow, Ana María Martins, Elena Lukina, Barry E. Rosenbloom, Özlem Göker-Alpan, Nora Watman, Amal El‐Beshlawy, Priya S. Kishnani, Maria Lúcia Alves Pedroso, Sebastiaan J.M. Gaemers, Regina Tayag, Michel Peterschmitt

    Publicado 2017
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  8. 8
    A Randomized Study of Alglucosidase Alfa in Late-Onset Pompe's Disease

    A Randomized Study of Alglucosidase Alfa in Late-Onset Pompe's Disease por Ans T. van der Ploeg, Paula R. Clemens, Deyanira Corzo, Diana M. Escolar, Julaine Florence, Geert Jan Groeneveld, S. Herson, Priya S. Kishnani, Pascal Laforêt, Stephen Lake, Dale J. Lange, Robert T. Leshner, J. Mayhew, Claire Morgan, Kenkichi Nozaki, Dorothy J. Park, Alan Pestronk, Barry E. Rosenbloom, Alison Skrinar, Carine I. van Capelle, Nadine A. M. E. van der Beek, Melissa Wasserstein, Saša Živković

    Publicado 2010
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  9. 9
    Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1

    Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1 por Pramod K. Mistry, Manisha Balwani, Hagit Baris, Hadhami Ben Turkia, T. Burrow, Joel Charrow, Gerald F. Cox, Sumita Danda, Marta Dragosky, Guillermo Drelichman, Amal El‐Beshlawy, Cristina Fraga, Selena Freisens, Sebastiaan J.M. Gaemers, Evgueniy Hadjiev, Priya S. Kishnani, Elena Lukina, Pierre Maison‐Blanche, Ana María Martins, Gregory M. Pastores, Мilan Petakov, Michel Peterschmitt, Hanna Rosenbaum, Barry E. Rosenbloom, Lisa H. Underhill, Timothy M. Cox

    Publicado 2018
    Enlace del recurso
    Carta
    Agregar a favoritos
    Guardado en:

Herramientas de búsqueda: